Ensign Peak Advisors Inc Sells 42,491 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ensign Peak Advisors Inc trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 548,498 shares of the medical equipment provider’s stock after selling 42,491 shares during the quarter. Ensign Peak Advisors Inc owned 0.15% of Intuitive Surgical worth $286,294,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Ethic Inc. raised its stake in Intuitive Surgical by 19.7% during the 4th quarter. Ethic Inc. now owns 42,022 shares of the medical equipment provider’s stock valued at $21,934,000 after purchasing an additional 6,906 shares during the last quarter. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $454,000. Fiduciary Trust Co lifted its stake in shares of Intuitive Surgical by 1.1% in the fourth quarter. Fiduciary Trust Co now owns 10,286 shares of the medical equipment provider’s stock valued at $5,369,000 after buying an additional 111 shares during the period. Deutsche Bank AG grew its position in Intuitive Surgical by 8.1% during the fourth quarter. Deutsche Bank AG now owns 1,307,253 shares of the medical equipment provider’s stock worth $682,334,000 after buying an additional 98,168 shares in the last quarter. Finally, Driehaus Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at about $601,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,313 shares of company stock valued at $17,229,143. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Piper Sandler decreased their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Stock Up 0.5 %

Shares of NASDAQ ISRG opened at $538.79 on Friday. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The firm’s 50-day simple moving average is $501.36 and its 200 day simple moving average is $534.58. The company has a market cap of $193.11 billion, a price-to-earnings ratio of 84.05, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the business earned $1.50 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.